Evidence map›Paper›PMID 31090539›Full record

ArticleeLife2019

IFNγ induces epigenetic programming of human T-bet

Esther Zumaquero, Sara L Stone, Christopher D Scharer, Scott A Jenks, Anoma Nellore, Betty Mousseau, Antonio Rosal-Vela, Davide Botta, John E Bradley, Wojciech Wojciechowski and 11 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 169 citations in OpenAlex.

  1. Elevated CD21Journal of clinical immunology · 2022
    Trial
  2. The Antigen Presenting Potential of CD21Frontiers in immunology · 2020
    Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Human CD21Journal of human immunity · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Esther ZumaqueroDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.ORCID 0000-0002-7631-7114
Sara L StoneDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.ORCID 0000-0002-1689-8148
Christopher D ScharerDepartment of Microbiology and Immunology, Division of Rheumatology, Emory University, Atlanta, United States.ORCID 0000-0001-7716-8504
Scott A JenksDepartment of Medicine, Division of Rheumatology, Emory University, Atlanta, United States.
Anoma NelloreDepartment of Medicine, Division of Infectious Disease, The University of Alabama at Birmingham, Birmingham, United States.
Betty MousseauDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.
Antonio Rosal-VelaDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.
Davide BottaDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.ORCID 0000-0003-3926-0662
John E BradleyDepartment of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, United States.
Wojciech WojciechowskiCenter for Pediatric Biomedical Research, Flow Cytometry Shared Resource Laboratory, University of Rochester School of Medicine and Dentistry, Rochester, United States.
Travis PtacekDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.
Maria I DanilaDepartment of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, United States.
Jeffrey C EdbergDepartment of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, United States.
S Louis BridgesDepartment of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, United States.
Robert P KimberlyDepartment of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, United States.
W Winn ChathamDepartment of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, United States.
Trenton R SchoebDepartment of Genetics, Animal Resources Program, The University of Alabama at Birmingham, Birmingham, United States.
Alexander F RosenbergDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.
Jeremy M BossDepartment of Microbiology and Immunology, Division of Rheumatology, Emory University, Atlanta, United States.
Ignacio SanzDepartment of Medicine, Division of Rheumatology, Emory University, Atlanta, United States.
Frances E LundDepartment of Microbiology, The University of Alabama at Birmingham, Birmingham, United States.ORCID 0000-0003-3083-1246
University of Alabama at Birmingham · USEmory University · USUniversity of Rochester · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Regulation of B cell Responses in SLE and Other Autoimmune DiseasesU19AI110483 · NIAID · EMORY UNIVERSITY · PI Ignacio E. Sanz · 2014 to 2026
$76.6M
National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
Regulation of Pathogenic Plasma Cells in Human SLEP01AI125180 · NIAID · EMORY UNIVERSITY · PI Ignacio E. Sanz · 2016 to 2026
$28.2M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008361 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YACOUBIAN, TALENE ALENE · 1992 to 2024
$16.8M
Virus-induced Cell Fate Decisions in Anti-Viral ImmunityU19AI109962 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LUND, FRANCES E. · 2014 to 2018
$11.6M
Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI ANOLIK, JENNIFER HOWITT · 2010 to 2014
$10.8M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
NCATS NIH HHS UL1 TR001417NCATS NIH HHS UL1 TR003096NCI NIH HHS P30 CA013148NCI NIH HHS UM1 CA183728NCRR NIH HHS G20 RR022807NIAID NIH HHS P01 AI078907NIAID NIH HHS P01 AI125180NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI110508NIAID NIH HHS R01 AI123733NIAID NIH HHS R37 AI049660NIAID NIH HHS U19 AI109962NIAID NIH HHS U19 AI110483NIAMS NIH HHS K23 AR062100NIAMS NIH HHS P30 AR048311NIDDK NIH HHS P30 DK079337NIGMS NIH HHS T32 GM008361NIGMS NIH HHS T32 GM008490NIH HHS 1P30 DK079337NIH HHS K23 AR062100NIH HHS P01 AI078907NIH HHS P01 AI125180NIH HHS R01 AI110508NIH HHS R01 AI123733NIH HHS R37 AI049660NIH HHS T32 GM008361NIH HHS U19 AI110483NIH HHS UL1 TR001417
6 · The paper itself

Abstract

Although B cells expressing the IFNγR or the IFNγ-inducible transcription factor T-bet promote autoimmunity in Systemic Lupus Erythematosus (SLE)-prone mouse models, the role for IFNγ signaling in human antibody responses is unknown. We show that elevated levels of IFNγ in SLE patients correlate with expansion of the T-bet expressing IgD

Indexed as

Cell DifferentiationEpigenesis, GeneticB-Lymphocyte SubsetsGene Regulatory NetworksHumansInterferon-gammaInterleukin-21InterleukinsLupus Erythematosus, SystemicT-bet Transcription FactorT-Box Domain ProteinsToll-Like Receptor 7Toll-Like Receptor 8Interferon-gammaInterleukin-21InterleukinsT-bet Transcription FactorT-Box Domain ProteinsToll-Like Receptor 7Toll-Like Receptor 8antibody secreting cellsB lymphocyteshumanimmunologyinflammationinterferonsmousesystemic lupus erythematosusT-bet

Identifiers

PMID31090539
PMCPMC6544433
OpenAlexW2949788114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.